ArticleJournal for immunotherapy of cancer2024

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

Emmanuelle Moraes Ribeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.